Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

Roger K. Cady,Sagar Munjal,Ryan J. Cady,Heather R. Manley,Elimor Brand-Schieber

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

2017

Roger K. Cady
Sagar Munjal
Ryan J. Cady
Heather R. Manley
Elimor Brand-Schieber

Background A 6-mg dose of SC sumatriptan is the most efficacious and fast-acting acute treatment for migraine, but a 3-mg dose of SC sumatriptan may improve tolerability while maintaining efficacy.

Keywords:

Anesthesia
Migraine
Sumatriptan
Crossover study
Medicine
Tolerability
Placebo
Phonophobia
Autoinjector
Nausea

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations